Beth P. Hecht J.D.
Net Worth

Last updated:

What is Beth P. Hecht J.D. net worth?

The estimated net worth of Ms. Beth P. Hecht J.D. is at least $3,947,662 as of 13 Mar 2020. She owns shares worth $417,922 as insider and has received compensation worth at least $3,529,740 in Xeris Biopharma Holdings, Inc..

What is the salary of Beth P. Hecht J.D.?

Ms. Beth P. Hecht J.D. salary is $588,290 per year as Senior Vice President, Gen. Counsel, Corporation Sec. & Director in Xeris Biopharma Holdings, Inc..

How old is Beth P. Hecht J.D.?

Ms. Beth P. Hecht J.D. is 61 years old, born in 1964.

What stocks does Beth P. Hecht J.D. currently own?

As insider, Ms. Beth P. Hecht J.D. owns shares in one company:

Company Title Shares Price per share Total value
Xeris Biopharma Holdings, Inc. (XERS) Senior Vice President, Gen. Counsel, Corporation Sec. & Director 57,083 $7.32 $417,922

What does Xeris Biopharma Holdings, Inc. do?

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.

Beth P. Hecht J.D. insider trading

Xeris Biopharma Holdings, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 4,000 N/A N/A
Purchase
Common Stock 4,000 N/A N/A
Purchase
Common Stock 2,500 N/A N/A

Xeris Biopharma Holdings key executives

Xeris Biopharma Holdings, Inc. executives and other stock owners filed with the SEC: